Cargando…
New Drug Developments for Neuromuscular Blockade and Reversal: Gantacurium, CW002, CW011, and Calabadion
PURPOSE OF REVIEW: The purpose of this chapter is to provide a brief review of the literature on the recent developments in neuromuscular blockade and reversal agents. RECENT FINDINGS: Novel drug development resulted in pharmacological advancements in neuromuscular management and led to a new series...
Autores principales: | de Boer, Hans Donald, Carlos, Ricardo Vieira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988786/ https://www.ncbi.nlm.nih.gov/pubmed/29904284 http://dx.doi.org/10.1007/s40140-018-0262-9 |
Ejemplares similares
-
Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular Blockade
por: Thilen, Stephan R., et al.
Publicado: (2016) -
Residual Neuromuscular Blockade and Postoperative Pulmonary Complications: What Does the Recent Evidence Demonstrate?
por: Cammu, Guy
Publicado: (2020) -
Sugammadex: Appropriate Use in the Context of Budgetary Constraints
por: Cammu, Guy
Publicado: (2018) -
Chronic exposure to dexamethasone may not affect sugammadex reversal of rocuronium-induced neuromuscular blockade: an in vivo study on rats
por: Park, Ha Yeon, et al.
Publicado: (2023) -
The use of sugammadex in an infant with prolonged neuromuscular blockade - A case report -
por: Kim, Hyunho, et al.
Publicado: (2022)